Hypertension resistant therapy — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Discuss adding low-dose spironolactone with monitoring
For resistant hypertension, low-dose spironolactone may be considered when potassium is suitable and renal function allows. Monitoring of renal function and electrolytes is essential. Potassium supplementation would increase hyperkalaemia risk. The other options do not represent evidence-based escalation of antihypertensive treatment.
Reference: BNF; NICE CKS